XBiotech partners with BioBridge to develop plasma-based Covid-19 therapy
US biopharmaceutical company XBiotech has partnered with BioBridge Global to develop potential plasma-based Covid-19 therapy using natural antibodies from the convalescent plasma of recovered patients. ... Read More